Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients

被引：0
|
作者：
Santulario-Verdu, L. [1 ]
Echeverry-Navarrete, E. [2 ]
Diez-Lopez, C. [2 ]
Canedo-Castelo, M. [1 ]
Juvany-Roig, R. [1 ]
Garcia-Romero, E. [2 ]
Roca-Elias, J. [2 ]
Manito-Lorite, N. [2 ]
Gonzalez-Costello, J. [2 ]
机构：
[1] Bellvitge Univ Hosp, Pharm, Barcelona, Spain
[2] Bellvitge Univ Hosp, Cardiol, Barcelona, Spain
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
512
引用
收藏
页码：S220 / S221
页数：2
相关论文
共 50 条
  • [1] Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
    Fang, Wendy
    McMahon, Lawrence P.
    Bloom, Stephen
    Garg, Mayur
    JGH OPEN, 2019, 3 (05): : 438 - 440
  • [2] Hypophosphatemia associated with use of intravenous ferric carboxymaltose
    Fierro, Maria Esther Proano
    Canete, Blanca Leticia Rodriguez
    Sobrino, Paula Sanchez
    Iraeta, Antonia Rego
    NUTRICION HOSPITALARIA, 2023, 40 (06) : 1301 - 1304
  • [3] Severe hypophosphatemia after ferric carboxymaltose intravenous treatment: Case series
    Nunez Montero, Melani
    Montane Esteva, Eva
    Hladun Alvaro, Olga
    Jimenez Capel, Yolanda
    Joaquin Ortiz, Clara
    Ramos Rodas, Analia
    Morales Triado, Anna
    Sancho Cerro, Ana
    Martinez Couselo, Silvia
    Guardiola Ponti, Helena
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 28 - 29
  • [4] Hypophosphatemia Is Common After Intravenous Ferric Carboxymaltose Infusion Among Patients With Symptomatic Heart Failure With Reduced Ejection Fraction
    Dashwood, Alexander
    Vale, Cassandra
    Laher, Shaaheen
    Chui, Fiona
    Hay, Karen
    Wong, Yee Weng
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (04): : 515 - 521
  • [5] FERRIC CARBOXYMALTOSE ASSOCIATED HYPOPHOSPHATEMIA
    Marampudi, Sindhu
    Shah, Monarch
    Kumar, Anubhav
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S34 - S34
  • [6] Hypophosphatemia related to intravenous iron therapy with ferric carboxymaltose: A case series
    Seng, Nigel Wei-Peng
    Barco, Jason Bae
    Wong, Marc Hai-Liang
    Lim, Kai-Xiong
    Peh, Wee-Ming
    Ng, Choong-Tatt
    Cushway, Tim
    Foo, Fung-Joon
    Koh, Frederick Hong-Xiang
    TRANSFUSION MEDICINE, 2023, 33 (06) : 503 - 508
  • [7] Hypophosphatemia Associated with Intravenous Ferric Carboxymaltose Complicated by Multiple Insufficiency Fractures
    Turin, Christie
    Hvisdas, Christopher
    Khan, Amna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 108 - 109
  • [8] Hypophosphatemia in HFrEF patients after iron supplementation. Ferric carboxymaltose vs Ferric derisomaltose
    Panagiotides, N.
    Weidenhammer, A.
    Arfsten, H.
    Prausmueller, S.
    Spinka, G.
    Bartko, P.
    Goliasch, G.
    Huelsmann, M.
    Pavo, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 95 - 96
  • [9] Severe Hypophosphatemia After Intravenous Administration of Iron Carboxymaltose in a Stable Renal Transplant Recipient
    Mani, Laila-Yasmin
    Nseir, Ghaleb
    Venetz, Jean-Pierre
    Pascual, Manuel
    TRANSPLANTATION, 2010, 90 (07) : 804 - 805
  • [10] Hypophosphatemia in children treated with ferric carboxymaltose
    Posod, Anna
    Schaefer, Benedikt
    Mueller, Thomas
    Zoller, Heinz
    Kiechl-Kohlendorfer, Ursula
    ACTA PAEDIATRICA, 2020, 109 (07) : 1491 - 1492
12345